Collagen biomarkers for arthritis applications
- PMID: 19690637
- PMCID: PMC2716783
Collagen biomarkers for arthritis applications
Keywords: ankylosing spondylitis; biomarkers; osteoarthritis; rheumatoid arthritis; type II collagen.
Figures
References
-
- Abadie E, Ethgen D, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Nuki G, Van De Putte L, Vanhaelst L, Reginster JY. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. Osteoarthritis & Cartilage. 2004;12:263–8. - PubMed
-
- Aigner T, Zhu Y, Chansky HH, Matsen FA, 3rd Maloney, W.J. and, Sandell LJ. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum. 1999;42:1443–50. - PubMed
-
- Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20:3–25. - PubMed
-
- Atley L, Shao P, Shaffer K, Eyre D. Matrix metalloproteinase- mediated release of immunoreactive telopeptides from cartilage type II collagen. Trans Orthop Res Soc. 1998;23:850.
-
- Atley L, Sharma L, Clemens J, Shaffer K, Pietka T, Riggins J, Eyre D. The collagen II CTx degradation marker is generated by collagenase 3 and in urine reflects disease burden in knee OA patients. Trans Orthop Res Soc. 2000;25:168.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials